CClinicalTrials.gg
RecruitingNCT06312605Updated Mar 15, 2024

The Adjunctive Role of Vitamin C on Pigment Recurrence (Randomized Clinical and Histological Trial)

A Phase 4 interventional study of Injectable applied vitamin C and Topical applied Vitamin C in Gingival Pigmentation, sponsored by Ain Shams University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-15.

Sponsored by Ain Shams University · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Registered 7 months after the study started (first participant enrolled Aug 2023, registered Mar 2024).
  • Started Aug 2023; still recruiting 3 years 2 months later.
Phase
Phase 4
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trial is to determine the role of vitamin C on recurrence of gingival pigment after patients who are healthy and esthetically concerned with it received surgical removal of this pigment. The main question[s] it aims to answer are:

  • Pigment recurrence after one year.
  • Patient satisfaction and histological response of tissues.

Participants will be asked to come on regular follow up visits one group will receive vitamin C injection other will be asked to apply topical vitamin C on a specific regimen.

Researcher will compare the groups who received injectable vitamin C with those who topically applied it to see the effect of each.

Read the detailed description

Esthetic dentistry is currently concerned with the pivotal role of the gingival tissue along with the teeth color, shape and position to achieve a harmonious attractive smile.

Physiological gingival hyperpigmentation is attributed to the increased activity of melanocytes rather than the increased number; consequently the gingiva in these individuals reveals increased density of melanophores. There are several pigments that contribute to physiological gingival hyper pigmentation, the main contributory pigment is melanin that is synthesized by melanocytes. Melanocytes form melanosomes granules from the amino acid tyrosine converting it into a molecule called dehydroxyphenylalanine (DOPA) through a hydroxylation process catalyzed by tryosinase enzyme.

Surgical and non-surgical approaches have been utilized to treat gingival hyperpigmentation. De-epithelizing of the target region is the main concept for most of the surgical interventions using different techniques as de-epithelizing using surgical blade or bur abrasion, cryosurgery and laser.

Among the minimal invasive non-surgical approaches of treating gingival hyperpigmentation was vitamin C that yielded promising results in the previous few years as proved in different clinical trials and have been recently documented in systemic review by .Vitamin C binds to melanin effectively once introduced into the tissues with a consequent deficient in calcium and copper affecting both melanin formation and transportation.

One of the main challenges after treating gingival hyperpigmentation is pigment recurrence. Different theories tried to explain the reasons for recurrence, some attributed it to the three dimensional shape of rete pegs, others attributed it to the migration theory and capability of cells to migrate from existing neighboring areas . Recurrence of pigment had shown to be inevitable occurring with nearly equal ranges in the previously illustrated techniques.

Sheel et al illustrated no recurrence of gingival pigmentation was observed after 9 months follow up with the topical application of vitamin C after surgical gingival depigmentation in a case report. This case report highlighted the ancillary role of vitamin C in decreasing the recurrence rate of gingival pigment after depigmentation.

According to the researcher knowledge, up to this time, there were no further studies investigating the long-term effect of using vitamin C to gain gingival color stability after depigmentation. This study was conducted to compare efficacy of vitamin C either locally injected or topically applied after surgical gingival depigmentation on recurrence of pigment and patient satisfaction over one-year follow up.

02

Conditions studied

  • Gingival Pigmentation

Browse trials for

Keywords

  • Gingival pigmentation /Pigment recurrence /Vitamin C
03

In context

Recurrence

4,279 studies on the registry are indexed under Recurrence; 987 are open to participants now.

This study's planned enrollment of 24 is below the median of 50 across 3,373 interventional studies indexed under Recurrence.

Browse Recurrence studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Both genders aged from 18-40. Systemically free patients from any disease as evidenced by the health questionnaire, using modified Cornell medical index and classified as ASA class I.

Patients who were diagnosed to have physiological gingival melanin pigmentation on the maxillary or mandibular keratinized gingiva with Dummett oral pigmentation score 2 or more.

Patients with thick gingival phenotype ≥ 1.5 mm.

Exclusion criteria

Exclusion criteria:

Pregnant or lactating females Smokers (water pipe, cigar or cigarette smoking). Patients taking or have taken any drug that may cause gingival depigmentation as chloroquine, minocycline, zidovudine, chlorpromazine, ketoconazole and bleomycin .

Any cause for supplemental intake of vitamin C. Reported allergy to ascorbic acid or to any of its derivatives as reported in health questionnaire .

Clinically diagnosed periodontitis regarding the following criteria probing depth >3mm, clinical attachment loss ≥ 1mm and bleeding on probing > 10% .

Patients with poor oral hygiene, incompliant to treatment and persistence gingival inflammation after phase I periodontal therapy.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Active comparator
    Intramucosal vitamin C injection

    After surgical gingival depigmentation, injectable vitamin C (Redox C 500 mg) using insulin syringe(29 Gauge 1cc 0.33mm x 8mm 5/16 needle) is applied at gingival sites 0.1 ml for each point that should be 3 mm. The regimen is done once weekly for a month then once a month for additional 5 months.

    Procedure: Injectable applied vitamin C

  • Active comparator
    (Vitamin C topical gel

    After surgical gingival depigmentation, patients in this group apply ascorbic acid containing gel prepared by Nawah Scientific Research Center. The micro emulsion was prepared by mixing tween 20 (4.66% w/w) as surfactant and isopropanol (2.3% w/w) as co-surfactant using magnetic stirring then diluted drop-wise with Vitamin C solution in water (10% w/w). The formed micro emulsion was then converted into gel using Poloxamer 407 (20% w/w) that was added at 4°C under continuous magnetic stirring

    Procedure: Topical applied Vitamin C

  • Placebo comparator
    Control group

    Surgical gingival depigmentation is carried out for these patients

    Procedure: Surgical depigmentation only

Interventions

  • ProcedureInjectable applied vitamin C

    Surgical gingival depigmentation is done for all participants, after then they receive injectable vitamin C

  • ProcedureTopical applied Vitamin C

    Surgical gingival depigmentation is done for all participants, after then they are instructed to apply topical vitamin C

  • ProcedureSurgical depigmentation only

    Surgical gingival depigmentation only without any drug

06

What researchers measure

Primary outcomes

  1. Pigmentation scores

    Dummet oral pigmentation index (DOPI) ,score (0-3), 0 = pink tissue \[no clinical pigmentation\]; 1 = mild light brown tissue \[mild clinical pigmentation\]; 2 = medium brown or mixed brown and pink tissue \[moderate clinical pigmentation\]; or 3 = deep brown/ blue-black tissue (heavy clinical pigmentation)

    Time frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

  2. Assessment of pigment surface area (SA)

    Standardized photos are taken and introduced into image J software after cropping interest area to calculate surface area of the pigment

    Time frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

  3. Assessment of pigment intensity in terms of mean darkness value (MDV)

    Standardized photos are taken and introduced into image J software after cropping interest area to calculate intensity of pigment

    Time frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

Secondary outcomes

  1. Patient satisfaction

    Satisfaction questionnaire Question Scoring Was the treatment painful? 1. no pain; 2. Mild pain; 3. Severe pain Did you notice a cosmetic change 1 week after the treatment? 1. not at all; 2. moderate; 3. marked Did you notice a cosmetic change 6 week after the treatment? 1. not at all; 2. moderate; 3. marked Did the treatment your expectations? 1. no; 2. yes; 3. Over and above Would you repeat the treatment if necessary? 1. no; 2. yes; 3. Over and above

    Time frame: After 12 months

  2. Histological response

    Biopsies taken and stained with Fontana-Masson stain to calculate area fraction of the stained cells

    Time frame: baseline - 6 months -after a year

07

Study locations

1 of 1 sites recruiting
  • Faculty AinShams University
    Cairo, Egypt
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06312605
Lead sponsor
Ain Shams University
Responsible party
Eman Osama Mohamed Hashem (Demonstrator at oral medicine and periodontology, Ain Shams University) — Principal investigator
First posted
Mar 15, 2024
Start date
Aug 1, 2023
Primary completion
Aug 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Mar 15, 2024

Study contacts

Eman O. Hashem, MSc
Contact
emanemmy123456@gmail.com
01025743781
Ola M. Ezzatt, Assistant Professor
Contact
d.ola@asfd.asu.edu.eg
0128794479
Hala K. Abd-El-Gaber, Professor
principal investigator · Professor of Oral Medicine, Oral Diagnosis and Periodontology Faculty of Dentistry - Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion